Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 4 3Phase NA 2Phase 2 1Phase 1/2 1

Status

Completed 4Unknown 2Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 3

Conditions

Neoplasms 3Venous Thromboembolism 2Upper Extremity Deep Vein Thrombosis 1Prevention of Venous Thromboembolism 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Completed × Rivaroxaban × Clear all
NCT03506815 2024-07-05

TRIM-Line

Ottawa Hospital Research Institute

Phase 3 Completed
105 enrolled 15 charts

Neoplasms, Upper Extremity Deep Vein Thrombosis

NCT03055026 2022-03-11

PRO-LAPSII

Fadoi Foundation, Italy

Phase 3 Completed
582 enrolled
Classical hematology

Prevention of Venous Thromboembolism

NCT02555878 2019-09-12

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Janssen Research & Development, LLC

Phase 3 Completed
841 enrolled 24 charts
Classical hematology

Neoplasms, Venous Thromboembolism

NCT02746185 2018-08-13

CASTA-DIVA

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
159 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡